Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inhalation Sciences Sweden ABXSAT:ISAB 29 Days Inventory is 140.52 as of Mar. 2026, which is 55% below its 10-year median of 310.35. GuruFocus rates XSAT:ISAB with a GF Score™ of 29/100 and a GF Value™ of kr0.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Inhalation Sciences Sweden AB ranks worse than 89.85% on this metric.
The historical rank and industry rank for Inhalation Sciences Sweden AB's Days Inventory or its related term are showing as below:
XSAT:ISAB'
s Days Inventory Range Over the Past 10 Years
Min: 168.65 Med: 310.35 Max: 2408.52
Current: 475.25
During the past 11 years, Inhalation Sciences Sweden AB's highest Days Inventory was 2408.52. The lowest was 168.65. And the median was 310.35.
XSAT:ISAB's Days Inventory is ranked worse than 89.85% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs XSAT:ISAB: 475.25
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inhalation Sciences Sweden AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.65.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Inhalation Sciences Sweden AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.69.
Inhalation Sciences Sweden AB (XSAT:ISAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Inhalation Sciences Sweden AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Inhalation Sciences Sweden AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Inhalation Sciences Sweden AB Days Inventory Related Terms
Inhalation Sciences Sweden AB Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inhalation Sciences Sweden AB Days Inventory Chart
XSAT:ISAB vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Inhalation Sciences Sweden AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inhalation Sciences Sweden AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inhalation Sciences Sweden AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Inhalation Sciences Sweden AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inhalation Sciences Sweden AB (XSAT:ISAB) has a Days Inventory of 140.52 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Inhalation Sciences Sweden AB and its competitors. This is 55% below median its historical median of 310.35. Over the past decade, Inhalation Sciences Sweden AB's Days Inventory has ranged from 168.65 to 2,408.52. According to the industry distribution chart, Inhalation Sciences Sweden AB ranks #708 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 89.8%.
Is Inhalation Sciences Sweden AB's Days Inventory too high?
Inhalation Sciences Sweden AB's current Days Inventory of 140.52 is 55% below median its 10-year median of 310.35. Over the past 10 years, this metric has ranged from a low of 168.65 to a high of 2,408.52. The Medical Devices & Instruments industry median Days Inventory is 179.12. Inhalation Sciences Sweden AB's value of 140.52 is 21.5% below this industry median. Based on the distribution chart, Inhalation Sciences Sweden AB ranks #708 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Inhalation Sciences Sweden AB has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inhalation Sciences Sweden AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Inhalation Sciences Sweden AB ranks #708 out of 788 companies for Days Inventory. This places Inhalation Sciences Sweden AB in the lower half of its industry. The industry median Days Inventory is 179.12. Inhalation Sciences Sweden AB's value of 140.52 is 21.5% below this benchmark. Historically, Inhalation Sciences Sweden AB's own Days Inventory has ranged from 168.65 to 2,408.52 over the past decade. While the company's 10-year median is 310.35 vs. the industry median of 179.12, Inhalation Sciences Sweden AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inhalation Sciences Sweden AB's current Days Inventory of 140.52 is 21.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Inhalation Sciences Sweden AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inhalation Sciences Sweden AB's current Days Inventory is 140.52, which is 55% below median its own 10-year median of 310.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inhalation Sciences Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Inhalation Sciences Sweden AB (XSAT:ISAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.39, compared to a current price of kr0.22 — trading 43.8% below its estimated fair value. The current Days Inventory is 140.52, which is 55% below median its 10-year median of 310.35 and 21.5% below the Medical Devices & Instruments industry median of 179.12. Inhalation Sciences Sweden AB's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Inhalation Sciences Sweden AB (XSAT:ISAB), the current Days Inventory is 140.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inhalation Sciences Sweden AB (XSAT:ISAB) Overvalued in 2026?
Based on GuruFocus' analysis, Inhalation Sciences Sweden AB stock appears to be undervalued.
The current stock price of kr0.22 is trading 43.8% below its estimated GF Value™ of kr0.39.
GuruFocus considers Inhalation Sciences Sweden AB to be Possible Value Trap.
Key valuation signals for XSAT:ISAB:
Days Inventory: 140.52 (55% below median its 10-year median of 310.35)
GF Value™: kr0.39 vs. price of kr0.22 (43.8% below fair value)
Industry Position: 21.5% below the Medical Devices & Instruments median (#708 of 788)
No single metric tells the full story. See the XSAT:ISAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inhalation Sciences Sweden AB Business Description
Inhalation Sciences Sweden AB develops and commercializes patented lab instrument for inhalation research. Its products include PreciseInhale an advanced laboratory system used to measure inhaled particles and their effect on lungs, and LaminarPace tool for drying small amounts of the drug substance.
29GF Score
Get the complete analysis for XSAT:ISAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ISAB has been successfully added to your 
